Pfizer set to develop new $200 million site

pharmafile | November 23, 2016 | News story | Manufacturing and Production, Research and Development Pfizer, manufacturing and production 

Pfizer plans to expand its operations in St. Louis, Missouri, by developing a $200 million facility in Chesterfield. The site will particularly focus upon research and development, creating more than 80 jobs and retaining 450 positions that already exist in the area.

Pfizer have held R&D facilities in the area for 13 years but this recent investment will see around 625 people employed on the new site. The facility will focus on the development biologic therapies and vaccines for clinical trials.

“Missouri is an important part of Pfizer’s R&D network, and we’re proud of the world-class employee base we’ve built here,” John Ludwig, senior vice president of BioTherapeutics Research for Pfizer, said in a statement. “Thanks to the support we’ve received from the state of Missouri, St. Louis County and Chesterfield, our new St. Louis laboratory facility will provide the right location and space as we continue to evolve our business over the coming years.”

Pfizer will potentially be able to receive an incentive package from the state for the construction of the site. Depending on job creation figures, it could receive as much as $5 million of the cost of the facility from the state and a further $800,000 if it provides a specified level of training to staff.

Construction of the site will begin in the middle of 2017, with completion of the site aiming to be sometime in 2020.

Related Content

Pfizer’s Velsipity approved by EC for ulcerative colitis treatment

Pfizer has announced that the European Commission (EC) has granted marketing authorisation for Velsipity (etrasimod) …

EC approves Pfizer’s Elrexfio for relapsed and refractory multiple myeloma

Pfizer has announced that the European Commission (EC) has granted conditional marketing authorisation for Elrexfio …

CDC Advisory Committee recommends Pfizer’s RSV vaccine

Pfizer has announced that the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee …

Latest content